Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Notes Payables (2020 - 2025)

Mainz Biomed's Notes Payables history spans 2 years, with the latest figure at $22754.0 for Q4 2021.

  • For Q4 2021, Notes Payables fell 7.23% year-over-year to $22754.0; the TTM value through Dec 2021 reached $22754.0, down 7.23%, while the annual FY2021 figure was $22754.0, 7.23% down from the prior year.
  • Notes Payables for Q4 2021 was $22754.0 at Mainz Biomed, down from $24527.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $24527.0 in Q4 2020 and bottomed at $22754.0 in Q4 2021.